These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 502566)

  • 1. Single versus double preoperative intralesional BCG in 13762 mammary adenocarcinoma.
    Lee YT
    J Surg Oncol; 1979; 12(3):243-52. PubMed ID: 502566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
    Lee YT
    Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of preoperative intralesional BCG and postoperative 5-FU chemotherapy in three adenocarcinoma lines in rats.
    Lee YT
    J Surg Oncol; 1979; 11(4):295-304. PubMed ID: 449359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
    Kreider JW; Bartlett GL; Boyer CM; Purnell DM
    Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of isonicotinic acid hydrazide on the intratumor injection of BCG.
    Sparks FC; Albert NE; Breeding JH
    J Natl Cancer Inst; 1977 Feb; 58(2):367-8. PubMed ID: 319244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment with the MER tubercle bacilli fraction on the survival of mice carrying mammary tumour isografts: injections of MER at the tumour site or at a distal location.
    Cohen D; Yron L; Haber M; Robinson E; Weiss DW
    Br J Cancer; 1975 Oct; 32(4):483-90. PubMed ID: 1212412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant preoperative and postoperative immunochemotherapy for mammary adenocarcinoma in rats.
    Sparks FC; O'Connell TX; Lee YT
    Surg Forum; 1973; 24():118-21. PubMed ID: 4618633
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapeutic effectiveness of BCG inactivated by various modalities.
    Kreider JW; Bartlett GL; Purnell DM
    Cancer; 1980 Aug; 46(3):480-7. PubMed ID: 7397622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma.
    Bogden AE; Esber HJ; Taylor DJ; Gray JH
    Cancer Res; 1974 Jul; 34(7):1627-31. PubMed ID: 4857731
    [No Abstract]   [Full Text] [Related]  

  • 11. Suitability of rat mammary adenocarcinoma 13762 as a model for BCG immunotherapy.
    Kreider JW; Bartlett GL; Purnell DM
    J Natl Cancer Inst; 1976 Apr; 56(4):797-802. PubMed ID: 815563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does isoniazid decrease the effect of BCG on local tumor growth?
    Sparks FC; Albert NE
    Surg Forum; 1975; 26():162-4. PubMed ID: 1216099
    [No Abstract]   [Full Text] [Related]  

  • 13. BCG therapy given as an adjuvant to surgery: prevention of death from metastases from mammary adenocarcinoma in rats.
    Sparks FC; O'Connell TX; Lee YT; Breeding JH
    J Natl Cancer Inst; 1974 Dec; 53(6):1825-6. PubMed ID: 4474413
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy of postoperative metastases of 13762A rat mammary adenocarcinoma: comparative effectiveness of BCG substrains and methods of preparation.
    Kreider JW; Bartlett GL; Purnell DM
    Cancer; 1980 Aug; 46(3):500-7. PubMed ID: 7397623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition or enhancement of rat mammary tumors dependent on dose BCG.
    Piessens WF; Campbell M; Churchill WH
    J Natl Cancer Inst; 1977 Jul; 59(1):207-11. PubMed ID: 875054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of cancer: induction of tumor immunity with a mixture of tumor cell-BCG, and the effect of intratumor injection of BCG and of nonliving BCG preparation.
    Tanaka T; Saito T
    Gan; 1975 Dec; 66(6):631-40. PubMed ID: 1225716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of murine tumor with syngeneic antitumor serum plus BCG.
    Yamazaki M; Saito M; Abe S; Mizuno D
    Jpn J Exp Med; 1983 Feb; 53(1):27-32. PubMed ID: 6876475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of spontaneous mammary carcinomas using direct injections of neuraminidase and BCG.
    Simmons RL; Rios A; Kersey JH
    J Surg Res; 1972 Feb; 12(2):57-61. PubMed ID: 4111004
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.
    Greager JA; Baldwin RW
    Cancer Res; 1978 Jan; 38(1):69-73. PubMed ID: 618584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.